Rimegepant (Nurtec ODT) for acute treatment of migraine

Med Lett Drugs Ther. 2020 May 4;62(1597):70-72.
No abstract available

Keywords: Aimovig; Ajovy; Emgality; Imitrex; NSAIDs; Nurtec ODT; Ubrelvy; Vyepti; adverse effects; dosage; drug interactions; efficacy; eptinezumab; erenumab; fremanezumab; galcanezumab; lactation; migraine; pregnancy; rimegepant; safety; sumatriptan; ubrogepant.

MeSH terms

  • Administration, Oral
  • Calcitonin Gene-Related Peptide Receptor Antagonists / administration & dosage*
  • Calcitonin Gene-Related Peptide Receptor Antagonists / adverse effects
  • Calcitonin Gene-Related Peptide Receptor Antagonists / pharmacology
  • Humans
  • Migraine Disorders / drug therapy*
  • Migraine Disorders / physiopathology
  • Piperidines / administration & dosage*
  • Piperidines / adverse effects
  • Piperidines / pharmacology
  • Pyridines / administration & dosage*
  • Pyridines / adverse effects
  • Pyridines / pharmacology

Substances

  • Calcitonin Gene-Related Peptide Receptor Antagonists
  • Piperidines
  • Pyridines
  • rimegepant sulfate